Phase 2 Lupus Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are willing to take part and have given their full informed consent to join the study.
- People aged between 18 and 70 years old (any gender).
- People who were diagnosed with Systemic Lupus Erythematosus (SLE) — a long-term immune system condition — at least 24 weeks before the screening visit.
- People whose SLE disease activity is measured at a score of 8 or higher on a standard medical scale called the SLEDAI-2K (confirm with trial site).
- People who have been on a stable SLE treatment for at least 4 weeks before being assigned to a study group, and who are expected to stay on that same dose throughout the trial.
Who may not be able to join:
- People with a history of certain infections as defined by the trial protocol (confirm with trial site for specific details).
- People who have certain medical conditions or disorders listed in the trial protocol (confirm with trial site for specific details).
- People who have a serious, uncontrolled, or unstable condition affecting any organ.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Xiaofeng, Zeng
Phone: 86+15900699091
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Proportion of subjects achieving the Systemic Lupus Erythematosus Responder Index-4 (SRI-4) at Week 32
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.